VANILLIN
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 152.0 | 1.2 | 1 | 3 | 47.0 | 2 | 0.13 |
- CAS
- 121335
- UNII
- CHI530446X
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 87 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Regulatory Status of Vanillin
| Gras - Generally recognized as safe. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 0.94MG |
| Oral | Capsule, Sustained Action | 0.94MG |
| Oral | Emulsion | |
| Oral | Powder | |
| Oral | Powder, For Suspension | 0.16% |
| Oral | Solution | 0.05% |
| Oral | Solution, Elixir | 0.0003% |
| Oral | Suspension | 0.1% |
| Oral | Syrup | |
| Oral | Tablet | 1.5MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 2.5MG |
| Oral | Tablet, Coated | 65.5MG |
| Oral | Tablet, Delayed Action | 0.8MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 1.16MG |
| Oral | Tablet, Enteric Coated Particles | 0.7MG |
| Oral | Tablet, Film Coated | 0.78MG |
| Oral | Tablet, Sustained Action | 3.4MG |
| Oral | Tablet, Sustained Action, Film Coated | 0.8MG |